CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −160 | $541.95 | $87K | 47,586 |
| 2026-06-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −480 | $544.26 | $261K | 47,106 |
| 2026-06-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −157 | $546.15 | $86K | 46,949 |
| 2026-06-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −881 | $547.65 | $482K | 46,068 |
| 2026-06-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −496 | $548.91 | $272K | 45,572 |
| 2026-06-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −400 | $551.74 | $221K | 45,172 |
| 2026-06-18 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 97,340 | ||
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −560 | $548.57 | $307K | 49,453 |
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −612 | $549.57 | $336K | 48,841 |
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,077 | $550.87 | $1.1M | 46,764 |
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,840 | $551.73 | $1.0M | 44,924 |
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −727 | $552.75 | $402K | 44,197 |
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,201 | $553.78 | $665K | 42,996 |
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,909 | $554.77 | $1.1M | 41,087 |
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −574 | $555.63 | $319K | 40,513 |
| 2026-06-17 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 12,410 | ||
| 2026-06-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-06-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −173 | $545.18 | $94K | 49,840 |
| 2026-06-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −525 | $546.04 | $287K | 49,315 |
Page 81 of 120 · 2,391 trades